Mammalian cells are an essential component of modern recombinant protein biotechnology. They exhibit highly complex protein folding and post-translational modification capabilities and generate recombinant proteins that are close to their native counterparts.

With more than 15 years of experience in recombinant protein expression, Sino Biological has developed a proprietary mammalian transient expression platform, with both HEK293 and CHO cell lines used as major workhorses. Our platform enables the high-throughput delivery and the generation high-quality of recombinant proteins and antibodies that are widely used in applications such as antigen preparation, antibody discovery, protein structure elucidation, and research for protein function.